DOI: 10.1002/alz.075555 ISSN: 1552-5260

CAM therapy initiative for Alzheimer’s patients : Asian perspectives

S P Rohan, Y Patil, N Verma
  • Psychiatry and Mental health
  • Cellular and Molecular Neuroscience
  • Geriatrics and Gerontology
  • Neurology (clinical)
  • Developmental Neuroscience
  • Health Policy
  • Epidemiology

Abstract

Background

In resource‐poor‐settings, Unlike Western nations monitoring Alzheimer’s‐treatment‐Adherence is low priority due to lack of training modules/funds/expertise. drug‐toxicity, social stigma causes high‐incidence of withdrawal from therapy. Hence our we‐analyzed locally available Complementary‐Alternative Medicines [CAM] in Alzheimer’s‐cases

Facilities for diagnosis/treatment located in major‐cities &are unaffordable to >75%. ADR’s & social stigma worsened situation. CAM must be incorporated along with standard DRUG’s to reduce ADR’s & control symptoms to get better treatment‐Adherence. Provide CAM to Traditional‐faith‐hearers. To assess CAM response to pain/fatigue/Myalgia/bed‐sores/wt‐loss, feeling of hopelessness, Dementia. Hence we combined CAM with standard‐drugs.

Method

n = 72 cases aged 60‐70 years enrolled. 30% females, 70% males. self report questionnaire distributed in NGO clinic. Mud therapy 60%, Bach‐flower 40%, Accupressure/Accupuncture 80%, Hydrotherapy 10%, Hypnotherapy 70%, ayurvedic therapy 80%, 60% on Unani, 50% Homeopathic, 60% Herbal‐Oil‐TFH massage therapy, 30% Aromatherapy.

Result

patients treated in 7 CAM sessions. responses evaluated by feedback‐Performa periodically to modify treatment. Symptom relief 92%, Psycholocal mood elevation 52%, willingness to shift back to std‐drug thrapy 80%. CAM 80% cheaper compared to std drugs

Conclusion

80% patients used & preferred CAMs. CAM effectively compliments Alzheimer’s treatment‐adherence. Community NGO’s must be part of such efforts to evolve newer concepts in Adherence. Realizing divergent versions of CAM multicentre study needed.

More from our Archive